|
1.
|
|
4 p, 111.4 KB |
SARS-CoV-2 vaccination in 361 non-transplanted patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria
/
Griffin, Morag (Department of Hematology. St James University Hospitals) ;
Eikema, Dirk-Jan (EBMT Statistical Unit) ;
Verheggen, Inge (EBMT Leiden Study Unit) ;
Kulagin, Alexander (Pavlov University) ;
Tjon, Jennifer M-L (Department of Hematology. Leiden University Medical Center) ;
Fattizzo, Bruno (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico) ;
Ingram, Wendy (Department of Hematology. University Hospital of Wales) ;
Zaidi, Uzma (National Institute of Blood Disease & Bone Marrow Transplantation) ;
Desnica, Lana (Department of Hematology. University Hospital Center Zagreb) ;
Giammarco, Sabrina (Dipartimento di Diagnostica per Immagini. Radioterapia Oncologica ed Ematologia. Fondazione Policlinico Universitario A. Gemelli IRCCS) ;
Drozd-Sokolowska, Joanna (Department of Hematology. Medical University of Warsaw) ;
Xicoy, Blanca (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Patriarca, Andrea (AOU Maggiore della Carità (Itàlia)) ;
Loschi, Michael (Cote d'Azur University) ;
Szmigielska-Kaplon, Anna (Department of Hematology. Copernicus Hospital) ;
Beier, F. (RWTH Aachen University) ;
Cignetti, Alessandro (University Division of Hematology) ;
Drexler, Beatrice (University Hospital Basel (Basilea, Suïssa)) ;
Gavriilaki, Eleni (Department of Hematology. George Papanicolaou General Hospital) ;
Lanza, Francesco (Hospital Santa Maria delle Croci) ;
Orvain, Corentin (Centre Hospitalier Universitaire d'Angers) ;
Risitano, Antonio Maria (Department of Hematology. AORN Moscati) ;
de la Camara, Rafael (Hospital Universitario de la Princesa (Madrid)) ;
Peffault de Latour, Régis (Hôpital Saint-Louis)
2024 -  10.3324/haematol.2023.283863
Haematologica, Vol. 109 Núm. 1 (january 2024) , p. 283-286
|
|
|
2.
|
|
8 p, 930.0 KB |
Ruxolitinib in refractory acute and chronic graft-versus-host disease : a multicenter survey study
/
Escamilla Gómez, V. (Universidad de Sevilla) ;
García-Gutiérrez, Valentín (University Hospital Ramon y Cajal) ;
López Corral, Lucía (Complejo Asistencial Universitario de Salamanca-IBSAL) ;
Garcia Cadenas, Irene (Institut d'Investigació Biomèdica Sant Pau) ;
Pérez Martínez, Ariadna (Hospital Clínic Universitari (València)) ;
Márquez Malaver, F.J. (Universidad de Sevilla) ;
Caballero Velazquez, Teresa (Universidad de Sevilla) ;
González Sierra, P.A. (Hospital Universitario (Granada)) ;
Viguria Alegría, M.C. (Complejo Hospitalario de Navarra) ;
Parra Salinas, I.M. (Hospital Universitario Miguel Servet (Saragossa)) ;
Calderón Cabrera, C. (Universidad de Sevilla) ;
González Vicent, M. (Hospital Infantil Universitario Niño Jesús (Madrid)) ;
Rodríguez Torres, N. (Universidad de Sevilla) ;
Parody Porras, R. (Instituto Catalá de Oncología Hospitalet) ;
Ferrá, Christelle (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Orti, Guillermo (Hospital Universitari Vall d'Hebron) ;
Valcárcel Ferreiras, D. (Hospital Universitari Vall d'Hebron) ;
de la Camara, Rafael (Hospital Universitario de la Princesa (Madrid)) ;
Molés, P. (Hospital Universitari i Politècnic La Fe (València)) ;
Velázquez-Kennedy, K. (Hospital Universitari Ramon y Cajal) ;
João Mende, M. (Complejo Asistencial Universitario de Salamanca-IBSAL) ;
Caballero, Dolores (Complejo Asistencial Universitario de Salamanca-IBSAL) ;
Pérez, Estefanía (Complejo Asistencial Universitario de Salamanca-IBSAL) ;
Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ;
Saavedra Gerosa, Silvana Daniela (Institut d'Investigació Biomèdica Sant Pau) ;
Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ;
Poch, M. (Clinic Hospital Universitari de Valencia) ;
Zudaire Ripa, M.T. (Complejo Hospitalario de Navarra) ;
Díaz Pérez, M.A. (Hospital Infantil Universitario Niño Jesús (Madrid)) ;
Molina Angulo, B. (Hospital Infantil Universitario Niño Jesús (Madrid)) ;
Sánchez Ortega, I. (Instituto Catalá de Oncología Hospitalet) ;
Sanz Caballer, J. (Hospital Universitari i Politècnic La Fe (València)) ;
Montoro Gómez, J. (Hospital Universitari i Politècnic La Fe (València)) ;
Espigado Tocino, I. (Universidad de Sevilla) ;
Pérez-Simón, J.A. (Universidad de Sevilla) ;
Universitat Autònoma de Barcelona
Graft-versus-host disease is the main cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation. First-line treatment is based on the use of high doses of corticosteroids. [...]
2020 - 10.1038/s41409-019-0731-x
Bone marrow transplantation, Vol. 55 Núm. 3 (january 2020) , p. 641-648
|
|
|
3.
|
|
8 p, 1.8 MB |
Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT) : an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE)
/
Saccardi, Riccardo (Careggi University Hospital (Florència, Itàlia)) ;
Putter, Hein (Leiden University Medical Center) ;
Eikema, Dirk-Jan (EBMT Statistical Unit Leiden) ;
Busto, María Paula (EBMT Registry) ;
McGrath, Eoin (ICCBBA (Barcelona, Espanya)) ;
Middelkoop, Bas (European Society for Blood and Marrow Transplantation-EBMT Registry) ;
Adams, Gillian (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Atlija, Marina (European Society for Blood and Marrow Transplantation-EBMT Registry) ;
Ayuk, Francis (University Medical Center Hamburg) ;
Baldomero, Helen (University Hospital Basel (Basilea, Suïssa)) ;
Beguin, Yves (CHU of Liège and University of Liège) ;
de la Camara, Rafael (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Cedillo Cedillo, Angel (Grupo Español de Trasplantes Hematopoyéticos y Terapia Celular) ;
Balari, Anna María Sureda (Hospital Universitari de Bellvitge) ;
Chabannon, Christian (Institut Paoli-Calmettes Comprehensive Cancer Centre) ;
Corbacioglu, Selim (University Children's Hospital Regensburg) ;
Dolstra, Harry (Radboud University Medical Center) ;
Duarte, Rafael (Universidad Autónoma de Madrid) ;
Duléry, Rémy (Sorbonne Université) ;
Greco, Raffaella (Autoimmune Diseases Working Party (Barcelona, Espanya)) ;
Gusi, Andreu (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Hamad, Nada (University of Notre Dame Australia) ;
Kenyon, Michelle (King's College Hospital NHS Foundation Trust) ;
Kroeger, Nicolaus (University Medical Center Hamburg) ;
Labopin, Myriam (European Society for Blood and Marrow Transplantation-EBMT Paris Study Office) ;
Lee, Julia (British Society of Blood and Marrow Transplantation and Cellular Therapy (Regne Unit)) ;
Ljungman, Per (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Manson, Lynn (Edinburgh & SE Scotland Clinical Transfusion Centre Patient Services (Regne Unit)) ;
Mensil, Florence (Agence de la Biomédecine) ;
Milpied, Noel (Centre Hospitalier Universitaire Bordeaux) ;
Mohty, Mohamad (Sorbonne University) ;
Oldani, Elena (Italian National BMT Registry) ;
Orchard, Kim (University Hospital Southampton NHS) ;
Passweg, Jakob (University Hospital Basel (Basilea, Suïssa)) ;
Pearce, Rachel (British Society of Blood and Marrow Transplantation and Cellular Therapy (Regne Unit)) ;
de Latour, Régis Peffault (BMT unit Paris Cité University) ;
Poirel, Hélène A. (Belgian Transplant Registry) ;
Rintala, Tuula (King's College Hospital NHS Foundation Trust) ;
Rizzo, J. Douglas (CIBMTR, Medical College of Wisconsin) ;
Ruggeri, Annalisa (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ;
Sanchez-Martinez, Carla (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Sanchez-Guijo, Fermin (CIC-University of Salamanca) ;
Sánchez-Ortega, Isabel (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Trnková, Marie (Czech registry Czech Republic) ;
Valcárcel, David (Vall d'Hebron Institut d'Oncologia) ;
Wilcox, Leonie (Australasian Bone Marrow Transplant Recipient Registry) ;
de Wreede, Liesbeth C. (Leiden University Medical Center) ;
Snowden, John A. (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ;
Universitat Autònoma de Barcelona
From 2016 EBMT and JACIE developed an international risk-adapted benchmarking program of haematopoietic stem cell transplant (HSCT) outcome to provide individual EBMT Centers with a means of quality-assuring the HSCT process and meeting FACT-JACIE accreditation requirements relating to 1-year survival outcomes. [...]
2023 - 10.1038/s41409-023-01924-6
Bone marrow transplantation, march 2023, p. 1-8
|
|
|
4.
|
|
9 p, 1.0 MB |
LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors
/
Cruz, David (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Rodríguez-Romanos, Rocío (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
González-Bartulos, Marta (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Garcia Cadenas, Irene (Institut d'Investigació Biomèdica Sant Pau) ;
de la Camara, Rafael (Hospital Universitario de la Princesa (Madrid)) ;
Heras, Inmaculada (Hospital General Universitario Morales Meseguer (Múrcia)) ;
Buño, Ismael (Hospital General Universitario Gregorio Marañón) ;
Santos, Nazly (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Lloveras, Natàlia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Velarde, Pilar (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Tuset, Esperanza (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Martínez, Carmen (Hospital Clínic i Provincial de Barcelona) ;
González, Marcos (Hospital Clínico Universitario (Salamanca)) ;
Sanz, Guillermo F. (Hospital Universitari i Politècnic La Fe (València)) ;
Ferrá, Christelle (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Sampol, Antonia (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ;
Coll, Rosa (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Pérez-Simón, Jose A. (Universidad de Sevilla) ;
López-Jiménez, Javier (Hospital Universitario Ramón y Cajal (Madrid)) ;
Jurado, Manuel (Hospital Universitario Virgen de las Nieves (Granada)) ;
Gallardo, David (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Universitat Autònoma de Barcelona
The association of polymorphisms in molecules involved in the immune response (checkpoint inhibitors) with the clinical outcome after allogeneic transplantation (alloHSCT) has been described. Lymphocyte Activation 3 (LAG3) is a surface protein that plays a regulatory role in immunity as an inhibitory immune checkpoint molecule. [...]
2023 - 10.3389/fimmu.2023.1066393
Frontiers in immunology, Vol. 14 (january 2023)
|
|
|
5.
|
|
10 p, 1.1 MB |
COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey
/
Ljungman, Per (Karolinska Institutet (Estocolm, Suècia)) ;
de la Camara, Rafael (Hospital Universitario de la Princesa (Madrid)) ;
Mikulska, Malgorzata (Division of Infectious Diseases. University of Genoa and Ospedale Policlinico San Martino) ;
Tridello, G. (Pediatric Hematology Oncology) ;
Aguado, Beatriz (Instituto de Investigación Hospital Universitario de la Princesa) ;
Zahrani, M.A. (King Abdul - Aziz Medical City) ;
Apperley, Jane (Centre for Haematology. Imperial College) ;
Berceanu, A. (Hopital Jean Minjoz) ;
Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ;
Calbacho, Maria (Hospital Universitario 12 de Octubre (Madrid)) ;
Ciceri, Fabio (Ospedale San Raffaele s.r.l.) ;
Lopez-Corral, L. (Hematology Department. Complejo Asistencial Universitario de Salamanca-IBSAL; Centro de Investigación del Cáncer-IBMCC) ;
Crippa, C. (Spedali Civili) ;
Fox, M.L. (Vall d'Hebron Institut d'Oncologia) ;
Grassi, A. (ASST Papa Giovanni XXIII) ;
Jimenez, M.J. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Demir, S.K. (HSCT unit. Demiroglu Bilim University) ;
Kwon, Mi (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
Llamas, C.V. (Hospital Universitario de Donostia (Sant Sebastià, País Basc)) ;
Lorenzo, J.L.L. (Hospital Universitario Fundación Jiménez Díaz) ;
Mielke, S. (Karolinska Institutet (Estocolm, Suècia). Department of Laboratory Medicine) ;
Orchard, K. (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ;
Porras, R.P. (Hospital Duran i Reynals (Hospitalet del Llobregat)) ;
Vallisa, D. (Hospital Guglielmo da Saliceto) ;
Xhaard, A. (Hôpital St. Louis) ;
Knelange, N.S. (EBMT Data Office. Department of Medical Statistics & Bioinformatics) ;
Cedillo, Angel (GETH Spanish Registry) ;
Kroeger, Nicolaus (Department of Stem cell Transplantation. University Hospital Eppendorf) ;
Piñana, José Luis (Hospital Clínic Universitari (València)) ;
Styczynski, Jan (Pediatric Hematology and Oncology. University Hospital. Collegium Medicum. Nicolaus Copernicus University Torun)
This study reports on 382 COVID-19 patients having undergone allogeneic (n = 236) or autologous (n = 146) hematopoietic cell transplantation (HCT) reported to the European Society for Blood and Marrow Transplantation (EBMT) or to the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH). [...]
2021 - 10.1038/s41375-021-01302-5
Leukemia, Vol. 35 Núm. 10 (october 2021) , p. 2885-2894
|
|
|
6.
|
|
16 p, 971.1 KB |
Cost-Effectiveness of Posaconazole Tablets for Invasive Fungal Infections Prevention in Acute Myelogenous Leukemia or Myelodysplastic Syndrome Patients in Spain
/
Cámara, Rafael (Hospital Universitario de la Princesa (Madrid)) ;
Gozalbo, Irmina (Outcomes10, Castellon, Spain) ;
Jurado, Manuel (Granada, Spain) ;
Sanz, Jaime (Valencia, Spain) ;
Aragón, Belén (Merck Sharp & Dome Corp, Madrid, Spain) ;
Grau, Santiago (Hospital del Mar (Barcelona, Catalunya)) ;
Universitat Autònoma de Barcelona
Posaconazole is superior to fluconazole (FLU) and itraconazole (ITRA) in the prevention of invasive fungal diseases (IFDs) in neutropenic patients with acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS). [...]
2017 - 10.1007/s12325-017-0600-1
Advances in Therapy, Vol. 34 (august 2017) , p. 2104-2119
|
|
visitante ::
identificación
alerta personal vía correo electrónico o subscríbase al 
canal RSS.
